Pregabalin in acute and chronic pain

Dalim Kumar Baidya, Anil Agarwal, Puneet Khanna, Mahesh Kumar Arora, Dalim Kumar Baidya, Anil Agarwal, Puneet Khanna, Mahesh Kumar Arora

Abstract

Pregabalin is a gamma-amino-butyric acid analog shown to be effective in several models of neuropathic pain, incisional injury, and inflammatory injury. In this review, the role of pregabalin in acute postoperative pain and in chronic pain syndromes has been discussed. Multimodal perioperative analgesia with the use of gabapentinoids has become common. Based on available evidence from randomized controlled trials and meta-analysis, the perioperative administration of pregabalin reduces opioid consumption and opioid-related adverse effects in the first 24 h following surgery. Postoperative pain intensity is however not consistently reduced by pregabalin. Adverse effects like visual disturbance, sedation, dizziness, and headache are associated with higher doses. The advantage of the perioperative use of pregabalin is so far limited to laparoscopic, gynecological, and daycare surgeries which are not very painful. The role of the perioperative administration of pregabalin in preventing chronic pain following surgery, its efficacy in more painful surgeries and surgeries done under regional anesthesia, and the optimal dosage and duration of perioperative pregabalin need to be studied. The efficacy of pregabalin in chronic pain conditions like painful diabetic neuropathy, postherpetic neuralgia, central neuropathic pain, and fibromyalgia has been demonstrated.

Keywords: Acute perioperative pain; chronic pain syndromes; pregabalin.

Conflict of interest statement

Conflict of Interest: None declared.

References

    1. Partridge B, Chaplan S, Sakamoto E, Yaksh T. Characterization of the effects of gabapentin and 3-isobutyl-g-aminobutyric acid on substance P-induced thermal hyperalgesia. Anesthesiology. 1998;88:196–205.
    1. Jun J, Yaksh T. The effect of intrathecal gabapentin and 3-isobutyl-g-aminobutyric acid on the hyperalgesia observed after thermal injury in the rat. Anesth Analg. 1998;86:348–54.
    1. Nozaki-Taguchi N, Chaplan SR, Higuera ES, Ajakwe RC, Yaksh TL. Vincristine-induced allodynia in the rat. Pain. 2001;93:69–76.
    1. Field MJ, Holloman EF, McCleary S, Hughes J, Singh L. Evaluation of gabapentin and S-(+)-3-isobutylgaba in a rat model of postoperative pain. J Pharmacol Exp Ther. 1997;282:1242–6.
    1. Field M, Oles R, Lewis A, McCleary S, Hughes J, Singh L. Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents. Br J Pharmacol. 1997;121:1513–22.
    1. Houghton AK, Lu Y, Westlund KN. S-(+)-3-Isobutylgaba and its stereoisomer reduces the amount of inflammation and hyperalgesia in an acute arthritis model in the rat. J Pharmacol Exp Ther. 1998;285:533–8.
    1. Ho KY, Gan TJ, Habib AS. Gabapentin and postoperative pain—a systematic review of randomized controlled trials. Pain. 2006;126:91–101.
    1. Tiippana EM, Hamunen K, Kontinen VK, Kalso E. Do Surgical Patients Benefit from Perioperative Gabapentin/Pregabalin? A Systematic Review of Efficacy and Safety. Anesth Analg. 2007;104:1545–56.
    1. Ben-Menachem E. Pregabalin pharmacology and its relevance to clinical practice. Epilepsia. 2004;45:13–8.
    1. Piyapolrungroj N, Li C, Bockbrader H, Liu G, Fleisher D. Mucosal uptake of gabapentin (neurontin) vs.pregabalin in the small intestine. Pharm Res. 2001;18:1126–30.
    1. Busch J, Strand J, Posvar E, Bockbrader H, Radulovic L. Pregabalin (CI-1008) multiple-dose pharmacokinetics and safety/tolerence in healthy volunteers. Pharm Sci. 1999;1:2033.
    1. Bockbrader H, Hunt T, Strand J, Posvar E, Sedman A. Pregabalin pharmacokinetics and safety in healthy volunteers: Results from two phase 1 studies. Neurology. 2000;54:A421.
    1. Su TZ, Feng MR, Weber ML. Mediation of highly concentrative uptake of pregabalin by L-type amino acid transport in Chinese hamster ovary and Caco-2 cells. J Pharmacol Exp Ther. 2005;313:1406–15.
    1. Freynhagen R, Strojek K, Griesing T, Whalen E, Balkenohl M. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of fble- and fixed-dose regimens. Pain. 2005;115:254–63.
    1. Bryans JS, Wustrow DJ. 3-Substituted GABA analogs with central nervous system activity: A review. Med Res Rev. 1999;19:149–77.
    1. Lauria-Horner BA, Pohl RB. Pregabalin: A new anxiolytic. Expert Opin Investig Drugs. 2003;12:663–72.
    1. Arikkath J, Campbell KP. Auxiliary subunits: Essential components of the voltage-gated calcium channel complex. Curr Opin Neurobiol. 2003;13:298–307.
    1. Bian F, Li Z, Offord J, Davis M, McCormick J, Taylor C. Calcium channel α(2)-δ type 1 subunit is the major binding protein for pregabalin in neocortex, hippocampus, amygdala, and spinal cord: An ex vivo autoradiographic study in α(2)-δ type 1 genetically modified mice. Brain Res. 2006;1:1–6.
    1. Belliotti T, Capiris T, Ekhato I, Kinsora J, Field M, Heffner T, et al. Structure-activity relationships of pregabalin and analogues that target the α(2)-δ protein. J Med Chem. 2005;48:2294–307.
    1. Gazulla J, Tintore M. The P/Q-type voltage-dependent calcium channel as pharmacological target in spinocerebellar ataxia type 6: Gabapentin and pregabalin may be of therapeutic benefit. Med Hypotheses. 2007;68:131–6.
    1. Jones D, Sorkin L. Systemic gabapentin and S(+)-3-isobutyl-γ- aminobutyric acid block secondary hyperalgesia. Brain Res. 1998;810:93–9.
    1. Dooley D, Donovan C, Pugsley T. Stimulus-dependent modulation of [3H]norepinephrine release from rat neocortical slices by gabapentin and pregabalin. J Pharmacol Exp Ther. 2000;295:1086–93.
    1. Dooley DJ, Mieske CA, Borosky SA. Inhibition of K+-evoked glutamate release from rat neocortical and hippocampal slices by gabapentin. Neurosci Lett. 2000;280:107–10.
    1. Fink K, Dooley DJ, Meder WP, Suman-Chauhan N, Duffy S, Clusmann H, et al. Inhibition of neuronal Ca 2+ influx by gabapentin and pregabalin in the human neocortex. Neuropharmacology. 2002;42:229–36.
    1. Errante L, Petroff OA. Acute effects of gabapentin and pregabalin on rat forebrain cellular GABA, glutamate, and glutamine concentrations. Seizure. 2003;12:300–6.
    1. Cunningham M, Woodhall G, Thompson S, Dooley D, Jones R. Dual effects of gabapentin and pregabalin on glutamate release at rat entorhinal synapses in vitro. Eur J Neurosci. 2004;20:1566–76.
    1. Micheva KD, Taylor CP, Smith SJ. Pregabalin reduces the release of synaptic vesicles from cultured hippocampal neurons. Mol Pharmacol. 2006;70:467–76.
    1. Bialer M, Johannessen SI, Kupferberg HJ, Levy RH, Loiseau P, Perucca E. Progress report on new antiepileptic drugs: A summary of the fourth Eilat conference (EILAT IV) Epilepsy Res. 1999;34:1–41.
    1. Welty D, Wang Y, Busch J, Taylor C, Vartanian M, Radulovic L. Pharmacokinetics and pharmacodynamics of CI-1008 (pregabalin) and gabapentin in rats with maximal electroshock. Epilepsia. 1977;388(suppl) Abstract 1.110.
    1. Lanneau C, Green A, Hirst W, Wise A, Brown J, Donnier E, et al. Gabapentin is not a GABA receptor agonist. Neuropharmacology. 2001;41:965–75.
    1. Randinitis EJ, Posvar EL, Alvey CW, Sedman AJ, Cook JA, Bockbrader HN. Pharmacokinetics of pregabalin in subjects with various degrees of renal function. J Clin Pharmacol. 2003;43:277–83.
    1. Hindmarch I, Trick L, Ridout F. A double-blind, placebo- and positive-internal-controlled (alprazolam) investigation of the cognitive and psychomotor profile of pregabalin in healthy volunteers. Psychopharmacology. 2005;183:133–43.
    1. Dolin SJ, Cashman JN. Tolerability of acute postoperative pain management: Nausea, vomiting, sedation, pruritis, and urinary retention.Evidence from published data. Br J Anaesth. 2005;95:584–91.
    1. Woolf C, Chong M. Preemptive analgesia-treating postoperative pain by preventing the establishment of central sensitization. Anesth Analg. 1993;77:362–79.
    1. Lascelles BD, Waterman AE, Cripps PJ, Livingston A, Henderson G. Central sensitization as a result of surgical pain: Investigation of the pre-emptive value of pethidine for ovariohysterectomy in the rat. Pain. 1995;62:201–12.
    1. Perkins F, Kehlet H. Chronic pain as an outcome of surgery.A review of predictive factors. Anesthesiology. 2000;93:1123–33.
    1. Aasvang E, Kehlet H. Chronic postoperative pain: The case of inguinal herniorrhaphy. Br J Anaesth. 2005;95:69–76.
    1. Dahl JB, Mathiesen O, Moiniche S. ‘Protective premedication’: An option with gabapentin and related drugs? A review of gabapentin and pregabalin in the treatment of post-operative pain. Acta Anaesthesiol Scand. 2004;48:1130–6.
    1. Rowbotham DJ. Gabapentin: A new drug for postoperative pain? Br J Anaesth. 2006;96:152–5.
    1. Turan A, Kaya G, Karamanlioglu B, Pamukcu Z, Apfel C. Effect of oral gabapentin on postoperative epidural analgesia. Br J Anaesth. 2006;96:242–6.
    1. Gilron I, Biederman J, Jhamandas K, Hong M. Gabapentin blocks and reverses antinociceptive morphine tolerance in the rat paw-pressure and tail-flick tests. Anesthesiology. 2003;98:1288–92.
    1. Hansen C, Gilron I, Hong M. The effects of intrathecal gabapentin on spinal morphine tolerance in the rat tail-flick and paw pressure tests. Anesth Analg. 2004;99:1180–4.
    1. Hill C, Balkenohl M, Thomas D, Walker R, Mathe H, Murray G. Pregabalin in patients with postoperative dental pain. Eur J Pain. 2001;5:119–24.
    1. Reuben SS, Buvanendran A, Kroin JS, Raghunathan K. The analgesic efficacy of celecoxib, pregabalin, and their combination for spinal fusion surgery. Anesth Analg. 2006;103:1271–7.
    1. Jokela R, Ahonen J, Tallgren M, Haanpaa M, Korttila K. A randomized controlled trial of perioperative administration of pregabalin for pain after laparoscopic hysterectomy. Pain. 2008;134:106–12.
    1. Ittichaikulthol W, Virankabutra T, Kunopart M, Khamhom W, Putarawuthichai P, Rungphet S. Effects of Pregabalin on Post operative Morphine Consumption and Pain after Abdominal Hysterectomy with/without Salphingo-oophorectomy: A Randomized, Double-Blind Trial. J Med Assoc Thai. 2009;92:1318–23.
    1. Kim SY, Jeong JJ, Chung WY, Kim HJ, Nam KH, Shim YH. Perioperative administration of pregabalin for pain after robot-assisted endoscopic thyroidectomy: A randomized clinical trial. Surg Endosc. 2010;24:2776–81.
    1. Mathiesen O, Rasmussen ML, Dierking G, Lech K, Hilsted KL, Fomsgaard JS, et al. Pregabalin and dexamethasone in combination with paracetamol for postoperative pain control after abdominal hysterectomy.A randomized clinical trial. Acta Anaesthesiol Scand. 2009;53:227–35.
    1. Chang SH, Lee HW, Kim HK, Kim SH, Kim DK. An evaluation of perioperative pregabalin for prevention and attenuation of postoperative shoulder pain after laparoscopic cholecystectomy. Anesth Analg. 2009;109:1284–6.
    1. Saraswat V, Arora V. Preemptive gabapentin vs pregabalin for acute post-operative pain after surgery under spinal anaesthesia. Indian J Anaesth. 2008;52:829–34.
    1. Buvanendran A, Kroin JS, Della-Valle CJ, Kari M, Moric M, Tuman KJ. Perioperative oral pregabalin reduces chronic pain after total knee arthroplasty: A prospective, randomized, controlled trial. Anesth Analg. 2010;110:199–207.
    1. Mathiesen O, Jacobsen LS, Holm HE, Randall S, Adamiec-Malmstroem L, Graungaad BK, et al. Pregabalin and dexamethasone for postoperative pain control: A randomized controlled study in hip arthroplasty. Br J Anaesth. 2008;101:535–41.
    1. Agarwal A, Gautam S, Gupta D, Agarwal S, Singh PK, Singh U. Evaluation of a single preoperative dose of pregabalin for attenuation of postoperative pain after laparoscopic cholecystectomy. Br J Anaesth. 2008;101:700–4.
    1. Paech MJ, Goy R, Chua S, Scott K, Christmas T, Doherty A. randomized, placebo-controlled trial of preoperative oral pregabalin for postoperative pain relief after minor gynecological surgery. Anesth Analg. 2007;105:1449–3.
    1. Freedman BM, O’Hara E. Pregabalin has opioid-sparing effects following augmentation mammaplasty. Aesthetic Surg J. 2008;28:421–4.
    1. Peng PW, Li C, Farcas E, Haley A, Wong W, Bender J. Use of low-dose pregabalin in patients undergoing laparoscopic cholecystectomy. Br J Anaesth. 2010;105:155–61.
    1. Zhang J, Ho KY, Wang Y. Efficacy of pregabalin in acute postoperative pain: A meta-analysis. Br J Anaesth. 2011;106:454–62.
    1. Pande AC, Feltner DE, Jefferson JW, Davidson JR, Pollack M, Stein MB, et al. Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: A placebo-controlled, multicentre study. J Clin Psychopharmacol. 2004;24:141–9.
    1. Pande AC, Crockatt JG, Feltner DE, Janney CA, Smith WT, Weisler R, et al. Pregabalin in generalized anxiety disorder: A placebo-controlled trial. Am J Psychiatry. 2003;160:533–40.
    1. White PF, Tufanogullari B, Taylor J, Klein K. The Effect of Pregabalin on Preoperative Anxiety and Sedation Levels: A Dose-Ranging Study. Anesth Analg. 2009;108:1140–5.
    1. Tassone DM, Boyce E, Guyer J, Nuzum D. Pregabalin: A novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders. Clin Ther. 2007;29:26–48.
    1. Moore RA, Straube S, Wiffen PJ, Derry S, McQuay HJ. Pregabalin for acute and chronic pain in adults. Cochrane Database Syst Rev. 2009;8:CD007076.
    1. Roth T, van Seventer R, Murphy TK. The effect of pregabalin on pain-related sleep interference in diabetic peripheral neuropathy or postherpetic neuralgia: A review of nine clinical trials. Curr Med Res Opin. 2010;26:2411–9.
    1. Smith K, Roberts M. Sequential medication strategies for postherpetic neuralgia: A cost-effectiveness analysis. J Pain. 2007;8:396–404.
    1. Tarride J, Gordon A, Vera-Llonch M, Dukes E, Rousseau C. Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: A Canadian perspective. Clin Ther. 2006;28:1922–34.
    1. D’Urso De Cruz E DR, Stacey B, Siffert J, Emir B. San Diego, California: American Diabetes Association 64th Scientific Sessions; 2005. Long-term treatment of painful DPH and PHN with pregabalin in treatmentrefractory patients. Poster presented at.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner